Effect of subfornical organ lesion on the development of mineralocorticoid-salt hypertension.
Accumulating evidence suggests that structures within the lamina terminalis; the organum vasculosm of the lamina terminalis (OVLT), the median preoptic nucleus (MnPO) and/or the subfornical organ (SFO); are required for the development of DOCA-salt hypertension. Lesion of the anteroventral tissue lining the third ventricle (AV3V), which destroys cell bodies in the OVLT and MnPO, as well as efferent projections from the SFO to the OVLT and MnPO, abolishes DOCA-salt hypertension in the rat. However, the individual contribution of these structures to DOCA-salt hypertension is unknown. The present study was designed to determine whether an intact SFO is required for hypertension development in the DOCA-salt model. In uninephrectomized SFO lesioned (SFOx; n=6) and SHAM (n=8) Sprague-Dawley rats, 24-h mean arterial pressure (MAP) and heart rate (HR) were continuously recorded telemetrically 4 days before and 36 days after DOCA implantation (100 mg/rat; s.c.); 24-h sodium and water balances were measured throughout the protocol. No differences in control MAP, HR, sodium and water balances were observed between groups. Following DOCA implantation, the magnitude of the elevation of MAP was similar between groups (approximately 40 mm Hg) so that by Day 40, MAP was 148+/-5 mm Hg in SFOx and 145+/-4 mm Hg in SHAM rats. The magnitude of decrease in HR from control values was similar in both groups. Differences in sodium and water balances were not observed between groups. We conclude that the SFO alone does not play a significant role in the development of mineralocorticoid-salt hypertension.
Osborn
John W
JW
Department of Physiology, University of Minnesota, 6-125 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA. osbor003@umn.edu
Jacob
Frederic
F
Hendel
Michael
M
Collister
John P
JP
Clark
Leah
L
Guzman
Pilar Ariza
PA
D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D004195:Disease Models, Animal; D004572:Electrolysis / Q000379:methods; D006339:Heart Rate / Q000502:physiology; D006973:Hypertension / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008901:Mineralocorticoids / Q000633:toxicity*; D009392:Nephrectomy / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage; D013356:Subfornical Organ / Q000293:injuries / Q000473:pathology / Q000502:physiology*; D013997:Time Factors
D008901:Mineralocorticoids; D017673:Sodium Chloride, Dietary